Ipamorelin vs Hexarelin: Head-to-Head Comparison
Hexarelin is the most potent GHRP available, producing the strongest GH release of any ghrelin mimetic, but at the cost of significant cortisol and prolactin elevation. Ipamorelin is preferred for long-term use due to its clean side-effect profile and lack of desensitization.
Side-by-Side Comparison
| Dimension | Ipamorelin | Hexarelin |
|---|---|---|
| Evidence Level | Phase II trials | Extensive clinical studies, cardioprotective data |
| FDA Status | Not approved | Not approved |
| GH Release Potency | Moderate | Highest of all GHRPs |
| Side Effects | Minimal cortisol/prolactin impact | Significant cortisol and prolactin elevation |
| Desensitization Risk | Low; suitable for long-term use | High; rapid receptor desensitization with chronic use |
| Unique Benefits | Clean GH pulse, good for stacking | Cardioprotective effects studied in heart failure patients |
| Cost | Moderate | Moderate |
Peptide Overviews
Ipamorelin
BHuman StudiesIpamorelin is a selective growth hormone secretagogue that stimulates growth hormone release from the pituitary gland without significantly affecting cortisol or prolactin levels.
Hexarelin
BHuman StudiesHexarelin is one of the most potent synthetic GH secretagogues. Research also suggests it has direct cardioprotective effects independent of its GH-releasing properties.
Ipamorelin vs Hexarelin: FAQ
Stay Informed on Peptide Research
Get weekly comparison updates, new study alerts, and regulatory changes.
No spam. Unsubscribe anytime.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.